BioRestorative Therapies (BRTX) Change in Inventory (2012 - 2015)
BioRestorative Therapies' (BRTX) quarterly Change in Inventory came in at $565.0 in Q2 2015, up 595.61% YoY from $81.22 in Q2 2014, and up 3238.89% on a QoQ basis from -$18.0 in Q1 2015.
BioRestorative Therapies (BRTX) Change in Inventory (2012 - 2015) Analysis & Trends
BioRestorative Therapies (BRTX) has 4 years of Change in Inventory data on file, last reported at $565.0 in Q2 2015.
- Quarterly Change in Inventory rose 595.61% year-over-year to $565.0 in Q2 2015, while the trailing twelve-month figure through Sep 2015 was $514.0 (up 188.62% YoY) and the FY2014 annual result came in at -$613.0, down 111.18% from the prior year.
- Change in Inventory improved to $565.0 in Q2 2015, from -$18.0 in the prior quarter.
- In the past five years, Change in Inventory ranged from a high of $12484.0 in Q4 2012 to a low of -$405.0 in Q3 2014.
- A 4-year average of $1789.9 and a median of -$25.5 in 2014 frame the typical range for Change in Inventory.
- Annual changes were most pronounced in 2014 — Change in Inventory tumbled 216.67% — and 2015, when it jumped 595.61%.
- Tracing BRTX's Change in Inventory over 4 years: stood at $12484.0 in 2012, then tumbled by 66.53% to $4179.0 in 2013, then sank by 100.79% to -$33.0 in 2014, then surged by 1812.12% to $565.0 in 2015.
- The last three Change in Inventory figures came in at $565.0 (Q2 2015), -$18.0 (Q1 2015), and -$33.0 (Q4 2014), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Inventory (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 138.92 Bn | 131.07 Bn | 2.84 Bn | 27.70 Mn |
| 2 | Regeneron Pharmaceuticals | 85.91 Bn | 77.91 Bn | 3.93 Bn | 28.20 Mn |
| 3 | Argenx Se | 64.87 Bn | 59.68 Bn | 1.37 Bn | - |
| 4 | Moderna | 58.18 Bn | 53.04 Bn | 52.00 Mn | 132.00 Mn |
| 5 | BeOne Medicines | 41.96 Bn | 36.87 Bn | 1.53 Bn | 47.15 Mn |
| 6 | Alnylam Pharmaceuticals | 31.53 Bn | 28.23 Bn | 992.69 Mn | -280,000.00 |
| 7 | BioNTech SE | 27.79 Bn | 9.40 Bn | 668.28 Mn | 135.26 Mn |
| 8 | Insmed | 27.46 Bn | 26.30 Bn | 358.27 Mn | 12.97 Mn |
| 9 | Royalty Pharma | 27.37 Bn | 26.53 Bn | - | - |
| 10 | BioRestorative Therapies | 1.94 Mn | -1.01 Mn | 17,964.00 | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2015 | 565.00 |
| Jun 30, 2015 | 565.00 |
| Mar 31, 2015 | -18.00 |
| Mar 31, 2015 | -18.00 |
| Dec 31, 2014 | -33.00 |
| Dec 31, 2014 | -33.00 |
| Sep 30, 2014 | -405.00 |
| Sep 30, 2014 | -405.00 |
| Jun 30, 2014 | -114.00 |
| Jun 30, 2014 | -114.00 |
| Mar 31, 2014 | -61.00 |
| Mar 31, 2014 | -61.00 |
| Sep 30, 2013 | 4,179.00 |
| Sep 30, 2013 | 4,179.00 |
| Jun 30, 2013 | -36.00 |
| Jun 30, 2013 | -36.00 |
| Mar 31, 2013 | 1,338.00 |
| Mar 31, 2013 | 1,338.00 |
| Dec 31, 2012 | 12,484.00 |
| Dec 31, 2012 | 12,484.00 |